Hua Medicine

02552

Company Profile

  • Business description

    Hua Medicine is an investment holding company. It is engaged in the development and commercialization of a first-in-class oral drug, Dorzagliatin or HMS5552, for the treatment of Type 2 diabetes. The group majorly operates in the PRC.

  • Contact

    Lane 36, Xuelin Road
    Hua Medicine, Building 2
    Pudong New Area
    Shanghai201203
    CHN

    T: +86 2138101800

    https://www.huamedicine.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2024

    Employees

    172

Stocks News & Analysis

stocks

3 "buy the dip" candidates with wide moats

Share price pullbacks can present an opportunity to buy high quality companies at attractive prices.
stocks

Undervalued ASX share hampered by delays in foreign expansion

A near monopoly in Australia pushes this company into global markets but progress has been slow.
stocks

Ask the analyst: Why has MinRes fallen so far?

Mineral Resources shares are down almost 50% year to date. Mark Taylor weighs in on some of the reasons why.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,515.203.70-0.04%
CAC 407,226.98199.90-2.69%
DAX 4019,033.64414.96-2.13%
Dow JONES (US)43,910.98382.15-0.86%
FTSE 1008,025.7799.42-1.22%
HKSE19,846.88580.05-2.84%
NASDAQ19,281.4017.36-0.09%
Nikkei 22539,376.09157.23-0.40%
NZX 50 Index12,684.5664.80-0.51%
S&P 5005,983.9917.36-0.29%
S&P/ASX 2008,255.6010.60-0.13%
SSE Composite Index3,421.9748.10-1.39%

Market Movers